239 related articles for article (PubMed ID: 22315282)
1. Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease.
Cunnington C; Van Assche T; Shirodaria C; Kylintireas I; Lindsay AC; Lee JM; Antoniades C; Margaritis M; Lee R; Cerrato R; Crabtree MJ; Francis JM; Sayeed R; Ratnatunga C; Pillai R; Choudhury RP; Neubauer S; Channon KM
Circulation; 2012 Mar; 125(11):1356-66. PubMed ID: 22315282
[TBL] [Abstract][Full Text] [Related]
2. GCH1 haplotype determines vascular and plasma biopterin availability in coronary artery disease effects on vascular superoxide production and endothelial function.
Antoniades C; Shirodaria C; Van Assche T; Cunnington C; Tegeder I; Lötsch J; Guzik TJ; Leeson P; Diesch J; Tousoulis D; Stefanadis C; Costigan M; Woolf CJ; Alp NJ; Channon KM
J Am Coll Cardiol; 2008 Jul; 52(2):158-65. PubMed ID: 18598896
[TBL] [Abstract][Full Text] [Related]
3. 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling.
Antoniades C; Shirodaria C; Warrick N; Cai S; de Bono J; Lee J; Leeson P; Neubauer S; Ratnatunga C; Pillai R; Refsum H; Channon KM
Circulation; 2006 Sep; 114(11):1193-201. PubMed ID: 16940192
[TBL] [Abstract][Full Text] [Related]
4. Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammation.
Antoniades C; Shirodaria C; Crabtree M; Rinze R; Alp N; Cunnington C; Diesch J; Tousoulis D; Stefanadis C; Leeson P; Ratnatunga C; Pillai R; Channon KM
Circulation; 2007 Dec; 116(24):2851-9. PubMed ID: 18040031
[TBL] [Abstract][Full Text] [Related]
5. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling.
Antoniades C; Bakogiannis C; Leeson P; Guzik TJ; Zhang MH; Tousoulis D; Antonopoulos AS; Demosthenous M; Marinou K; Hale A; Paschalis A; Psarros C; Triantafyllou C; Bendall J; Casadei B; Stefanadis C; Channon KM
Circulation; 2011 Jul; 124(3):335-45. PubMed ID: 21730307
[TBL] [Abstract][Full Text] [Related]
6. Cell type-specific recycling of tetrahydrobiopterin by dihydrofolate reductase explains differential effects of 7,8-dihydrobiopterin on endothelial nitric oxide synthase uncoupling.
Schmidt K; Kolesnik B; Gorren AC; Werner ER; Mayer B
Biochem Pharmacol; 2014 Aug; 90(3):246-53. PubMed ID: 24863258
[TBL] [Abstract][Full Text] [Related]
7. Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling: relative importance of the de novo biopterin synthesis versus salvage pathways.
Crabtree MJ; Tatham AL; Hale AB; Alp NJ; Channon KM
J Biol Chem; 2009 Oct; 284(41):28128-28136. PubMed ID: 19666465
[TBL] [Abstract][Full Text] [Related]
8. Effects Of Endothelin-1 On Intracellular Tetrahydrobiopterin Levels In Vascular Tissue.
Cerrato R; Crabtree M; Antoniades C; Kublickiene K; Schiffrin EL; Channon KM; Böhm F
Scand Cardiovasc J; 2018 Jun; 52(3):163-169. PubMed ID: 29566572
[TBL] [Abstract][Full Text] [Related]
9. Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease.
Shirodaria C; Antoniades C; Lee J; Jackson CE; Robson MD; Francis JM; Moat SJ; Ratnatunga C; Pillai R; Refsum H; Neubauer S; Channon KM
Circulation; 2007 May; 115(17):2262-70. PubMed ID: 17420345
[TBL] [Abstract][Full Text] [Related]
10. Increasing tetrahydrobiopterin in cardiomyocytes adversely affects cardiac redox state and mitochondrial function independently of changes in NO production.
Sethumadhavan S; Whitsett J; Bennett B; Ionova IA; Pieper GM; Vasquez-Vivar J
Free Radic Biol Med; 2016 Apr; 93():1-11. PubMed ID: 26826575
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydrobiopterin recycling, a key determinant of endothelial nitric-oxide synthase-dependent signaling pathways in cultured vascular endothelial cells.
Sugiyama T; Levy BD; Michel T
J Biol Chem; 2009 May; 284(19):12691-700. PubMed ID: 19286667
[TBL] [Abstract][Full Text] [Related]
12. Induction of vascular GTP-cyclohydrolase I and endogenous tetrahydrobiopterin synthesis protect against inflammation-induced endothelial dysfunction in human atherosclerosis.
Antoniades C; Cunnington C; Antonopoulos A; Neville M; Margaritis M; Demosthenous M; Bendall J; Hale A; Cerrato R; Tousoulis D; Bakogiannis C; Marinou K; Toutouza M; Vlachopoulos C; Leeson P; Stefanadis C; Karpe F; Channon KM
Circulation; 2011 Oct; 124(17):1860-70. PubMed ID: 21969008
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydrobiopterin Supplementation Improves Endothelial Function But Does Not Alter Aortic Stiffness in Patients With Rheumatoid Arthritis.
Mäki-Petäjä KM; Day L; Cheriyan J; Hall FC; Östör AJ; Shenker N; Wilkinson IB
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26896473
[TBL] [Abstract][Full Text] [Related]
14. Tetrahydrobiopterin improves endothelial function in patients with cystic fibrosis.
Jeong JH; Lee N; Tucker MA; Rodriguez-Miguelez P; Looney J; Thomas J; Derella CC; El-Marakby A; Musall JB; Sullivan JC; McKie KT; Forseen C; Davison GW; Harris RA
J Appl Physiol (1985); 2019 Jan; 126(1):60-66. PubMed ID: 30433862
[TBL] [Abstract][Full Text] [Related]
15. Acute oral tetrahydrobiopterin administration ameliorates endothelial dysfunction in systemic sclerosis.
Machin DR; Clifton HL; Richardson RS; Wray DW; Donato AJ; Frech TM
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):167-172. PubMed ID: 28980911
[TBL] [Abstract][Full Text] [Related]
16. Plasma tetrahydrobiopterin/dihydrobiopterin ratio: a possible marker of endothelial dysfunction.
Takeda M; Yamashita T; Shinohara M; Sasaki N; Takaya T; Nakajima K; Inoue N; Masano T; Tawa H; Satomi-Kobayashi S; Toh R; Sugiyama D; Nishimura K; Yokoyama M; Hirata K; Kawashima S
Circ J; 2009 May; 73(5):955-62. PubMed ID: 19293532
[TBL] [Abstract][Full Text] [Related]
17. No effect of acute tetrahydrobiopterin (BH
Bisconti AV; Garten RS; Broxterman RM; Jarrett CL; Park SH; Shields KL; Clifton HL; Ratchford SM; Reese V; Zhao J; Wray DW; Richardson RS
J Appl Physiol (1985); 2022 Mar; 132(3):773-784. PubMed ID: 35112931
[TBL] [Abstract][Full Text] [Related]
18. Acute Tetrahydrobiopterin Improves Endothelial Function in Patients With COPD.
Rodriguez-Miguelez P; Gregg J; Seigler N; Bass L; Thomas J; Pollock JS; Sullivan JC; Dillard TA; Harris RA
Chest; 2018 Sep; 154(3):597-606. PubMed ID: 29705218
[TBL] [Abstract][Full Text] [Related]
19. Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease.
Maier W; Cosentino F; Lütolf RB; Fleisch M; Seiler C; Hess OM; Meier B; Lüscher TF
J Cardiovasc Pharmacol; 2000 Feb; 35(2):173-8. PubMed ID: 10672847
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydrobiopterin restores endothelial function in long-term smokers.
Ueda S; Matsuoka H; Miyazaki H; Usui M; Okuda S; Imaizumi T
J Am Coll Cardiol; 2000 Jan; 35(1):71-5. PubMed ID: 10636262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
